Table 1.
Characteristics of 23 included guidelines on screening for breast cancer.
| Countries/Regions | Publication years | Publication organizations | Names of guidelines | Number of updated versions | Publication years of old versions |
|---|---|---|---|---|---|
| Global [16] | 2014 | WHO | WHO position paper on mammography screening | None | None |
| The United States [17] | 2019 | ACP | Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians | 1 | 2007 |
| The United States [18] | 2019 | NCCN | Breast Cancer Screening and Diagnosis, Version 1.2019 | 9 | 1998 2003 2006 2010 2013 2015 2016 2017 2018 |
| The United States [19] | 2017 | ACR | ACR Appropriateness Criteria® Breast Cancer Screening | 2 | 1998 2013 |
| The United States [20] | 2018 | ACR | Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR | None | None |
| The United States [21] | 2017 | ACR | Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging | None | None |
| The United States [22] | 2010 | ACR and SBI | Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer | None | None |
| The United States [7] | 2016 | USPSTF | Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement | 3 | 1996 2002 2009 |
| The United States [23] | 2015 | ACS | Breast Cancer Screening for Women at Average Risk 2015 Guideline Update From the American Cancer Society | 3 | 1992 1997 2003 |
| The United States [24] | 2019 | ACOG | Breast Cancer Risk Assessment and Screening in Average-Risk Women | 3 | 2003 2011 2017 |
| Europe [25] | 2020 | ECIBC | Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines | None | None |
| Europe [8] | 2019 | ESMO | Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up | 1 | 2015 |
| Europe [26] | 2010 | EUSOMA | Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group | None | None |
| Canada [27] | 2018 | CTFPHC | Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer | 3 | 1994 2001 2011 |
| Germany [28] | 2018 | AWMF, DKG, and DKH | The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer | 1 | 2012 |
| Australia [29] | 2015 | Cancer Australia | Early detection of breast cancer | 2 | 2009 2004 |
| Singapore [30] | 2010 | MOH | Cancer screening | None | None |
| Malaysia [31] | 2019 | MOH | Management of Breast Cancer (3rd Edition) | 2 | 2002 2010 |
| Japan [9] | 2016 | NCC Japan | The Japanese Guidelines for Breast Cancer Screening | 2 | 2013 2015 |
| China [32] | 2021 | NCC China | China Guideline for the Screening and Early Detection of Female Breast Cancer (2021, Beijing) | None | None |
| Hong Kong, China [33] | 2018 | CEWG | Recommendations on prevention and screening for breast cancer in Hong Kong | None | None |
| Brazil [34] | 2018 | MOH | Guidelines for early detection of breast cancer in Brazil. II – New national recommendations, main evidence, and controversies | None | None |
| Brazil [35] | 2017 | CBR, SBM, and FEBRASGO | Breast Cancer Screening: Updated Recommendations of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Breast Disease Society, and Brazilian Federation of Gynecological and Obstetrical Associations | None | None |
Abbreviations: ACOG: American College of Obstetricians and Gynecologists; ACP: American College of Physicians; ACR: American College of Radiology; ACS: American Cancer Society; AWMF: German Association of Scientific Medical Societies; CBR: Brazilian College of Radiology and Diagnostic Imaging; CEWG: Cancer Expert Working Group; CTFPHC: Canadian Task Force on Preventive Health Care; DKG: German Cancer Society; DKH: German Cancer Aid; ECIBC: European Commission Initiative on Breast Cancer; ESMO: European Society for Medical Oncology; EUSOMA: European Society of Breast Cancer Specialists; FEBRASGO: Brazilian Federation of Gynecological and Obstetrical Associations; MOH: Ministry of Health; NCC: National Cancer Centre; NCCN: National Comprehensive Cancer Network; SBI: Society of Breast Imaging; SBM: Brazilian Society for Breast Disease; USPSTF: U.S. Preventive Services Task Force; WHO: World Health Organization.